SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Mondelez International, Inc. (MDLZ) (CIK 0001103982) (MDLZ) — Sep 2, 2022

Mondelez International, Inc. (MDLZ) (CIK 0001103982)
Date: Sept. 2, 2022 · CIK: 0001103982 · Accession: 0000000000-22-009590

AI Filing Summary & Sentiment

File numbers found in text: 001-16483

Date
September 2, 2022
Author
Not clearly detected
Form
UPLOAD
Company
Mondelez International, Inc. (MDLZ) (CIK 0001103982)

Letter

United States securities and exchange commission logo September 2, 2022 Luca Zaramella Chief Financial Officer Mondelez International, Inc. 905 West Fulton Market, Suite 200 Chicago, IL 60607 Re:Mondelez International, Inc. Definitive Proxy Statement on Schedule 14A Filed April 6, 2022 File No. 001-16483 Dear Mr. Zaramella: We have limited our review of your most recent definitive proxy statement to those issues we have addressed in our comments. Please respond to these comments by confirming that you will enhance your future proxy disclosures in accordance with the topics discussed below as well as any material developments to your risk oversight structure. For guidance, refer to Item 407(h) of Regulation S-K. Definitive Proxy Statement on Schedule 14A filed April 6, 2022 General 1.Please expand your discussion of the reasons you believe that your leadership structure is appropriate, addressing your specific characteristics or circumstances. In your discussion, please also address how the experience of your Lead Director is brought to bear in connection with your board’s role in risk oversight. 2.Please expand upon the role that your Lead Director plays in the leadership of the board. For example, please enhance your disclosure to address whether or not your Lead Director may:

•represent the board in communications with stakeholders other than "major shareholders," as well as any threshold to qualify as such; or •require board consideration of, and/or override your CEO on, any risk matters.

FirstName LastNameLuca Zaramella Comapany NameMondelez International, Inc. September 2, 2022 Page 2 FirstName LastName Luca Zaramella Mondelez International, Inc. September 2, 2022 Page 2 3.Please expand upon how your board administers its risk oversight function. For example, please disclose:

•the timeframe over which you evaluate risks (e.g., short-term, intermediate-term, or long-term) and how you apply different oversight standards based upon the immediacy of the risk assessed; •whether you consult with outside advisors and experts to anticipate future threats and trends, and how often you re-assess your risk environment; •how the board interacts with management to address existing risks and identify significant emerging risks; •to whom your Chief Compliance Officer reports; and •how your risk oversight process aligns with your disclosure controls and procedures. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christopher Dunham at (202) 551-3783 or Barbara Jacobs at (202) 551- 3735 with any questions. Sincerely, Division of Corporation Finance Disclosure Review Program

Show Raw Text
United States securities and exchange commission logo
September 2, 2022
Luca Zaramella
Chief Financial Officer
Mondelez International, Inc.
905 West Fulton Market, Suite 200
Chicago, IL 60607
Re:Mondelez International, Inc.
Definitive Proxy Statement on Schedule 14A
Filed April 6, 2022
File No. 001-16483
Dear Mr. Zaramella:
            We have limited our review of your most recent definitive proxy statement to those issues
we have addressed in our comments.
            Please respond to these comments by confirming that you will enhance your future proxy
disclosures in accordance with the topics discussed below as well as any material developments
to your risk oversight structure. For guidance, refer to Item 407(h) of Regulation S-K.
Definitive Proxy Statement on Schedule 14A filed April 6, 2022
General
1.Please expand your discussion of the reasons you believe that your leadership structure is
appropriate, addressing your specific characteristics or circumstances. In your discussion,
please also address how the experience of your Lead Director is brought to bear in
connection with your board’s role in risk oversight.
2.Please expand upon the role that your Lead Director plays in the leadership of the board.
For example, please enhance your disclosure to address whether or not your Lead Director
may:

•represent the board in communications with stakeholders other than "major
shareholders," as well as any threshold to qualify as such; or
•require board consideration of, and/or override your CEO on, any risk matters.

 FirstName LastNameLuca  Zaramella
 Comapany NameMondelez International, Inc.
 September 2, 2022 Page 2
 FirstName LastName
Luca  Zaramella
Mondelez International, Inc.
September 2, 2022
Page 2
3.Please expand upon how your board administers its risk oversight function. For example,
please disclose:

•the timeframe over which you evaluate risks (e.g., short-term, intermediate-term, or
long-term) and how you apply different oversight standards based upon the
immediacy of the risk assessed;
•whether you consult with outside advisors and experts to anticipate future threats and
trends, and how often you re-assess your risk environment;
•how the board interacts with management to address existing risks and identify
significant emerging risks;
•to whom your Chief Compliance Officer reports; and
•how your risk oversight process aligns with your disclosure controls and procedures.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Please contact Christopher Dunham at (202) 551-3783 or Barbara Jacobs at (202) 551-
3735 with any questions.
Sincerely,
Division of Corporation Finance
Disclosure Review Program